SCHEMBL1644186

SCHEMBL1644186

CN(NC(=O)O)C(C)(C)C

nearest known ligand 0.32

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.32
TSHR P16473 1/20 0.32
POLB P06746 1/20 0.31
KDM7A Q6ZMT4 1/20 0.31
PHF8 Q9UPP1 1/20 0.31
KDM2A Q9Y2K7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL407819 0.79 KDM5B (0.35)
SCHEMBL7718758 0.70 POLB (0.38) POLB
SCHEMBL21585749 0.69 EGLN1 (0.44) ALDH1A1
SCHEMBL1526296 0.69
Formic Acid SCHEMBL4660060 0.67
SCHEMBL18488505 0.65
SCHEMBL9740779 0.65
Dimethylamine SCHEMBL15271682 0.65 KDM7A (0.44) KDM7APHF8KDM2A
SCHEMBL25352936 0.62 SLC6A5 (0.37)
Bicarbonate SCHEMBL10734019 0.61 ALDH1A1 (0.37) ALDH1A1TSHRPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220267303-A1 Compounds and Methods for Treating or Preventing Bacterial Infections BAYLOR COLLEGE OF MEDICINE 2022-08-25 US disclosed
US-8633323-B2 Process for preparing bis(thiohydrazide amides) SYNTA PHARMACEUTICALS CORP. (US) 2014-01-21 US disclosed
US-20110098476-A1 PROCESS FOR PREPARING BIS(THIOHYDRAZIDE AMIDES) SYNTA PHARMACEUTICALS CORP. 2011-04-28 US disclosed
WO-2009123704-A2 PROCESS FOR PREPARING BIS(THIOHYDRAZIDE AMIDES) SYNTA PHARMACEUTICALS CORP. (US) 2009-10-08 WO disclosed
EP-1737851-A1 TETRAHYDROBENZAZEPINE DERIVATIVES AS MODULATORS OF DOPAMINE D3 RECEPTORS (ANTIPSYCHOTIC AGENTS) GLAXO GROUP LIMITED (GB) 2007-01-03 EP disclosed
EP-1124827-B1 3-(SUBSTITUTED PHENYL)-5-(SUBSTITUTED HETEROCYCLYL)-1,2,4-TRIAZOLE COMPOUNDS DOW AGROSCIENCES LLC (US) 2005-11-30 EP disclosed
WO-2005087764-A1 TETRAHYDROBENZAZEPINE DERIVATIVES AS MODULATORS OF DOPAMINE D3 RECEPTORS (ANTIPSYCHOTIC AGENTS) GLAXO GROUP LIMITED (GB) 2005-09-22 WO disclosed
US-6413997-B1 INSECTICIDES, MITICIDES DOW AGROSCIENCES LLC 2002-07-02 US disclosed
EP-0922043-B1 PESTICIDAL 3-(SUBSTITUTED PHENYL)-5-(THIENYL OR FURYL)-1,2,4-TRIAZOLES DOW AGROSCIENCES LLC (US) 2002-01-30 EP disclosed
US-6262305-B1 Process and intermediates for preparing 3-(substituted phenyl)-5-(thienyl or furyl)-1,2,4-triazole compounds DOW AGROSCIENCES LLC 2001-07-17 US disclosed
EP-1113004-A2 Intermediates for producing 3-(substituted phenyl)-5-(thienyl or furyl)-1,2,4-triazole compounds Dow Agrosciences LLC (US) 2001-07-04 EP disclosed
US-6015826-A INSECTICIDES, APHIDICIDES, AND MITICIDES DOW AGROSCIENCES LLC 2000-01-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220267303-A1 Compounds and Methods for Treating or Preventing Bacterial Infections OXA1L, MMP8, OGG1 ALDH1A1 349/4885TSHR 4547/4885POLB 206/4885
US-20110098476-A1 PROCESS FOR PREPARING BIS(THIOHYDRAZIDE AMIDES) H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, H1-3, CYB5R3 ALDH1A1 1070/4885TSHR 7/4885POLB 1182/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.